| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/30/2008 | CA2309766C Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor |
| 09/30/2008 | CA2305704C Peptide/lipid complex formation by co-lyophilization |
| 09/30/2008 | CA2295604C Lo-cd2a antibody and uses thereof for inhibiting t cell activation and proliferation |
| 09/30/2008 | CA2285573C A method for stimulating red blood cell production |
| 09/30/2008 | CA2261989C Recombinant pox virus for immunization against tumor-associated antigens |
| 09/30/2008 | CA2259140C Method of activating dendritic cells |
| 09/30/2008 | CA2082382C Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy |
| 09/30/2008 | CA1341581C Leukaemia inhibitory factor |
| 09/30/2008 | CA1341580C Tissue-type plasminogen activator mutants |
| 09/27/2008 | CA2582846A1 Methods for bone augmentation involving a bone augmentation agent and a bone cement |
| 09/25/2008 | WO2008116171A1 Cyclic receptor-associated protein (rap) peptides |
| 09/25/2008 | WO2008116078A2 Stimulation of an immune response by cationic lipids |
| 09/25/2008 | WO2008116053A2 Fap-activated chemotherapeutic compounds, and methods of use thereof |
| 09/25/2008 | WO2008115863A2 Neuroprotection by psammaplysene a |
| 09/25/2008 | WO2008115631A2 Plant-produced compositions for treating papillomavirus infection and related methods |
| 09/25/2008 | WO2008115597A2 Cytokine muteins and methods for enhancing immune responses in mammals |
| 09/25/2008 | WO2008115569A1 Method for inhibiting immune responses in mammals using muteins of fas ligand |
| 09/25/2008 | WO2008115525A2 Metal-binding therapeutic peptides |
| 09/25/2008 | WO2008115443A1 Kinase protein binding inhibitors |
| 09/25/2008 | WO2008115411A1 Combination enzyme therapy for digestion of dietary gluten |
| 09/25/2008 | WO2008115390A2 Methods of using defensins to treat diabetes |
| 09/25/2008 | WO2008115303A2 Potent and selective mediators of cholesterol efflux |
| 09/25/2008 | WO2008115039A1 Novel use of ec-sod and method for preparing thereof |
| 09/25/2008 | WO2008114889A1 Oral vaccine |
| 09/25/2008 | WO2008114577A2 Antibacterial peptide |
| 09/25/2008 | WO2008114488A1 Therapeutic agent for autoimmune skin disease containing polypeptide as active ingredient |
| 09/25/2008 | WO2008114487A1 Therapeutic agent for autoimmune skin disease containing polypeptide as active ingredient |
| 09/25/2008 | WO2008114082A1 Methods, processes and compositions comprising the protein calmodulin (cam) for treatment of damaged or ageing skin, and/or hair loss |
| 09/25/2008 | WO2008114037A1 Treatment of inflammation and/or endotoxic shock |
| 09/25/2008 | WO2008113796A1 Cholesterol lowering protein hydrolysates |
| 09/25/2008 | WO2008113606A1 Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use |
| 09/25/2008 | WO2008113597A1 Peptides for treating multiple myeloma |
| 09/25/2008 | WO2008113589A1 Methods for industrial scale production of therapeutic complement factor h preparations from human plasma |
| 09/25/2008 | WO2008113536A1 Neurotrophic peptides |
| 09/25/2008 | WO2008113500A1 Methods and compounds for modulating inflammatory processes |
| 09/25/2008 | WO2008113145A1 Proteins from the webs of nephilengys cruentata, avicularia juruensis and parawixia bistriata spiders |
| 09/25/2008 | WO2008096359A3 Agents for the treatment of multiple sclerosis and methods of using same |
| 09/25/2008 | WO2008089003A3 System for optical stimulation of target cells |
| 09/25/2008 | WO2008087224A3 Mutated netrin 4, fragments thereof and uses thereof as drugs |
| 09/25/2008 | WO2008085728A3 Combination medication for treating the effects of stomach acid reduction medication on bone integrity |
| 09/25/2008 | WO2008085260A3 Photosensitive polypeptides and methods of their production and use |
| 09/25/2008 | WO2008067223A3 Il-17a/f heterodimeric polypeptides and therapeutic uses thereof |
| 09/25/2008 | WO2008060776A3 Atap peptides, nucleic acids encoding the same and associated methods of use |
| 09/25/2008 | WO2008060368A3 Transglutaminase-binding peptides and methods of use |
| 09/25/2008 | WO2008048348A3 Broad spectrum antiviral compositions |
| 09/25/2008 | WO2008033890A3 Compositions containing alpha-1-antitrypsin and methods for use |
| 09/25/2008 | WO2007149406A8 Modified coagulation factor ix polypeptides and use thereof for treatment |
| 09/25/2008 | WO2007079130A3 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 09/25/2008 | WO2007058982A3 Mntf differentiation and growth of stem cells |
| 09/25/2008 | WO2007058878A3 Mechanisms of osteoinduction by lim mineralization protein-1 (lmp-1) |
| 09/25/2008 | WO2006069246A3 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 09/25/2008 | US20080235822 Nucleic acids encoding chimeric polypeptides allowing expression of plant-noxious proteins |
| 09/25/2008 | US20080234656 Method for altering drug pharmacokinetics based on medical delivery platform |
| 09/25/2008 | US20080234621 Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content |
| 09/25/2008 | US20080234471 Dna sequence; open-reading frame; genetic engineering |
| 09/25/2008 | US20080234470 Kcnb: a novel potassium channel protein |
| 09/25/2008 | US20080234469 Binding to monoclonal antibodies; antitumor agents |
| 09/25/2008 | US20080234468 Isdolated nucleic acids; coding polypeptide; therapy for central nervous system disorders |
| 09/25/2008 | US20080234467 Modifying amino acid sequences conjugate comprising: coupling N- alpha -protected amino acid to an immobilized peptide sequence, deprotecting sequence, cleaving peptide conjugate, recovering product |
| 09/25/2008 | US20080234430 Providing a multi-arm block copolymer, the block copolymer comprising a central core molecule comprising a residue of a polyol, and at least three copolymer arms covalently attached to the central core molecule, entrapping a biologically active agent within the hydrophobic core region |
| 09/25/2008 | US20080234393 Compounds and methods for detection of carcinomas and their precursor lesions |
| 09/25/2008 | US20080234379 Therapeutic methods employing nitric oxide precursors |
| 09/25/2008 | US20080234228 Boronic acid salts |
| 09/25/2008 | US20080234219 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures |
| 09/25/2008 | US20080234217 Double stranded nucleotide sequences for use as tools in tissue targeted gene expression inhibition and treatment of cancer, vascular, neuronal and endocrine diseases |
| 09/25/2008 | US20080234216 TGF-beta type receptor cDNAs encoded products and uses therefor |
| 09/25/2008 | US20080234214 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration |
| 09/25/2008 | US20080234206 Prodrugs of Phentermine |
| 09/25/2008 | US20080234205 Antineoplastic peptides |
| 09/25/2008 | US20080234204 Methods for evaluating and implementing prostate disease treatments |
| 09/25/2008 | US20080234203 Use of Substances Having Oxytocin Antagonistic Properties |
| 09/25/2008 | US20080234202 Reacting carboxylic acid or amide derivative with amine compound to obtain amino acid analogs, peptides containing analogs of basic amino acids lysine and arginine; desamino amino acid compound, of the extended or truncated peptide; pain, psychosis, obesity; cosmetics |
| 09/25/2008 | US20080234201 BH3 peptides and method of use thereof |
| 09/25/2008 | US20080234200 Saline formulation of a glucose-regulating peptide (amylin, synthtic hormone pramlintide, glucon like peptide-1, extendins), water, sodium chloride and a buffering agent; identical ph and osmolarity for both transmucosal glucose regulating peptide and saline water; antidiabetic, antiobesity agent |
| 09/25/2008 | US20080234199 Chemical Compounds |
| 09/25/2008 | US20080234198 Amino acid sequences having C-terminal extensions or modifications, used as activators of G-protein coupled receptor kinases (VPAC2), for treating non-insulin-dependent or insulin-dependent diabetes; antidiabetic agents |
| 09/25/2008 | US20080234197 Method(s) of stabilizing and potentiating the actions and administration of brain-derived neurotrophic factor (BDNF) |
| 09/25/2008 | US20080234196 First series of intranasal administration of E-selectin over period of two weeks, followed by a booster administration of E-selectin after at least two weeks from the first administration of E-selectin to minimize brain tissue damage |
| 09/25/2008 | US20080234195 Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations |
| 09/25/2008 | US20080234194 Growth factor mediated cosmeceuticals and use thereof to enhance skin quality |
| 09/25/2008 | US20080234193 Von Willebrand factor-and factor VIII-polymer conjugates having a releasable linkage |
| 09/25/2008 | US20080234192 Compositions and methods of use for treating cardiovascular disease |
| 09/25/2008 | US20080234191 Depleting complement; treatment of diseases such as reperfusion injury, autoimmune diseases, and other diseases of increased complement activation; increasing the efficiency and/or effectiveness of gene therapy; may be chemically linked to an antibody with an affinity for a specific tissue |
| 09/25/2008 | US20080234190 Administering a glial growth factor protein to treat nervous system conditions associated with demyelination, especially of Schwann cells; multiple sclerosis |
| 09/25/2008 | US20080234189 Treatment of inflammation related to an autoimmune disease, such as asthma, arthritis, psoriasis, or inflammatory bowel disease by adminstering an extracellular adherence protein; recruitment of leukocytes or neutrophils to an inflammation site is prevented |
| 09/25/2008 | US20080234188 Antimicrobial Peptides |
| 09/25/2008 | US20080234187 In particular amidated, acetylated, phosphorylated and/or glycosylated derivatives; diagnostic agents including a nucleic acid or messenger RNA coding for the cytokine; isolated from human hemofiltrate |
| 09/25/2008 | US20080234186 Synthetic, for the enhancement of fertility, egg production and/or spermatogenesis |
| 09/25/2008 | US20080234185 Use of Dmbt1 for Capturing Sulphate and Phosphate Group Exposing Agents |
| 09/25/2008 | US20080234184 These membrane domains are of viral envelope proteins that allow viruses to anchor to the target cells that they will infect; allows coexpression of the TME1 and TME2 membrane domains of the hepatitis C virus envelope proteins |
| 09/25/2008 | US20080234183 Predicting or designing, detecting, and/or verifying a novel cell-penetrating peptide that mimics cellular effector activity; vectors; treating and/or preventing infectious diseases, diabetes type I and II, Alzheimer's Disease, Parkinson's Disease, and cancer. |
| 09/25/2008 | US20080234182 Compound having a symmetry and size capable of fitting to an opening of the pore of a pore-forming pathogen for binding such that upon binding, the pore or prepore is blocked, especially cyclodextrin derivatives; combatting biological warfare; drug screening; drug design |
| 09/25/2008 | US20080234181 Antisense Epidermal Growth Factor Receptor/oligonucleotides in which guanidinium residue substitution (N-(2-aminoethyl) D-arginine) is distributed throughout the oligonucleotide; excellent uptake into mammalian cells; resists nucleases and proteases both outside and inside the cell(s) |
| 09/25/2008 | US20080234180 Particularly oral mucositis as a result of chemotherapy or radiotherapy |
| 09/25/2008 | US20080234179 Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form |
| 09/25/2008 | US20080234178 Administering a mixture including a cell delivery agent and a cell death agent; reduced the level of the Bcl-2 antagonist protein Bim present in rheumatoid arthritis synovial tissue |
| 09/25/2008 | US20080234177 Targeting-enhanced activation of galectins |
| 09/25/2008 | US20080234176 Modified peptides and their uses |
| 09/25/2008 | US20080234175 Reaction mixture of a complex of an negative-sense NS1 protein of influenza virus, or a douple stranded (ds)RNA binding fragment of it, and a dsRNA that binds the protein; targets for drug design; small scale and/or high-throughput screening for inhibitors of interactions between NS1A or NS1B, and dsRNA, |
| 09/25/2008 | US20080234132 Inhibitors of DNA gyrase; for inhibiting bacterial infections, treating cancer, controlling plant growth and seed germination |